Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles
- 14 December 2017
- journal article
- review article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 29 (3) , 604-612
Abstract
As nanoparticles exhibit unique properties attractive for vaccine development, they have been progressively implemented as antigen delivery platforms and immune potentiators. Recently, cell membrane-coated nanoparticles have provided a novel approach for intercepting and neutralizing bacterial toxins by leveraging their natural affinity to cellular membranes. Such toxin–nanoparticle assemblies, termed nanotoxoids, allow rapid loading of different types of toxins and have been investigated for their ability to effectively confer protection against bacterial infection. This topical review will cover the current progress in antibacterial vaccine nanoformulations and highlight the nanotoxoid platform as a novel class of nanoparticulate vaccine. We aim to provide insights into the potential of nanotoxoids as a platform that is facile to implement and can be broadly applied to help address the rising threat of super pathogens.Keywords
Funding Information
- National Eye Institute (R01EY025947)
- Defense Threat Reduction Agency (HDTRA1-14-1-0064)
This publication has 94 references indexed in Scilit:
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficileMicrobiology, 2013
- A biomimetic nanosponge that absorbs pore-forming toxinsNature Nanotechnology, 2013
- Reorienting our view of particle-based adjuvants for subunit vaccinesProceedings of the National Academy of Sciences, 2012
- Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsionsVaccine, 2011
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences, 2011
- Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug deliveryMolecular Membrane Biology, 2010
- A self-assembling peptide acting as an immune adjuvantProceedings of the National Academy of Sciences, 2009
- A Vault Nanoparticle Vaccine Induces Protective Mucosal ImmunityPLOS ONE, 2009
- Targeting Vault Nanoparticles to Specific Cell Surface ReceptorsACS Nano, 2008
- Pathogenesis of Methicillin‐ResistantStaphylococcus aureusInfectionClinical Infectious Diseases, 2008